Skip to main content
Signal8

Mazabraud Yann

SEC insider (Form 3/4/5 filer). CIK 0001774702. EVP, Head of International at RHYTHM PHARMACEUTICALS, INC. (RYTM). 23 reported Form 4/5 transactions since Sep 2024; latest on Aug 12, 2026. Located in BOSTON, MA.

Companies Mazabraud Yann has filed insider reports for

  • RHYTHM PHARMACEUTICALS, INC. (RYTM): Officer, EVP, Head of International
Mazabraud Yann profile photo

Mazabraud Yann

CIK: 0001774702

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)11 (47.8%)

Position reduction

Option Exercises (M)8 (34.8%)

Derivative conversions

Awards (A)4 (17.4%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

RHYTHM PHARMACEUTICALS, INC. logo
RYTM

RHYTHM PHARMACEUTICALS, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (23 total)

  • RHYTHM PHARMACEUTICALS, INC. logo
    RYTM

    RHYTHM PHARMACEUTICALS, INC.

    Aug 12, 2026
    Sale
    Direct
    1K shares at avg. $112.86$113K
  • RHYTHM PHARMACEUTICALS, INC. logo
    RYTM

    RHYTHM PHARMACEUTICALS, INC.

    Aug 12, 2026
    Sale
    Direct
    2.3K shares at avg. $111.80$257K
  • RHYTHM PHARMACEUTICALS, INC. logo
    RYTM

    RHYTHM PHARMACEUTICALS, INC.

    Aug 12, 2026
    Sale
    Direct
    3.6K shares at avg. $114.70$413K
  • RHYTHM PHARMACEUTICALS, INC. logo
    RYTM

    RHYTHM PHARMACEUTICALS, INC.

    Aug 12, 2026
    Sale
    Direct
    18.2K shares at avg. $116.49$2.1M
  • RHYTHM PHARMACEUTICALS, INC. logo
    RYTM

    RHYTHM PHARMACEUTICALS, INC.

    Aug 12, 2026
    Sale
    Direct
    14.6K shares at avg. $115.43$1.7M
  • RHYTHM PHARMACEUTICALS, INC. logo
    RYTM

    RHYTHM PHARMACEUTICALS, INC.

    Aug 12, 2026
    Sale
    Direct
    17.3K shares at avg. $117.47$2.0M
  • RHYTHM PHARMACEUTICALS, INC. logo
    RYTM

    RHYTHM PHARMACEUTICALS, INC.

    Aug 12, 2026
    Exercise
    Direct
    46.6K shares at avg. $6.80$317K
  • RHYTHM PHARMACEUTICALS, INC. logo
    RYTM

    RHYTHM PHARMACEUTICALS, INC.

    Apr 1, 2026
    Exercise
    Direct
    12.9K shares-
  • RHYTHM PHARMACEUTICALS, INC. logo
    RYTM

    RHYTHM PHARMACEUTICALS, INC.

    Mar 2, 2026
    Award

    Stock Options (Right to Buy)

    Direct
    35K shares-
  • RHYTHM PHARMACEUTICALS, INC. logo
    RYTM

    RHYTHM PHARMACEUTICALS, INC.

    Feb 14, 2026
    Exercise
    Direct
    10K shares-

1-10 of 23